Compounds > quinuclidines
Page last updated: 2024-08-18

quinuclidines and Adenocarcinoma

quinuclidines has been researched along with Adenocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Abrams, SL; Akula, SM; Cervello, M; Cocco, L; Duda, P; Emma, MR; Follo, ML; Gizak, A; Martelli, AM; McCubrey, JA; Montalto, G; Rakus, D; Ratti, S; Steelman, LS1
Azar, WJ; Clemons, NJ; Cullinane, C; Duong, CP; Fennell, CM; Haupt, S; Haupt, Y; Liu, DS; Montgomery, KG; Phillips, WA; Read, M; Wiman, KG1
Balu, S; Buchner, D; Feinberg, B; Gilmore, J; Haislip, S; Jackson, J; Jain, G1
Bergman, J; Bykov, VJ; Selivanova, G; Stridh, H; Westman, J; Wiman, KG; Zache, N1
Chow, WH; Finkle, WD; Frankl, H; Fraumeni, JF; McLaughlin, JK; Ziel, HK1

Other Studies

5 other study(ies) available for quinuclidines and Adenocarcinoma

ArticleYear
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.
    Cells, 2022, 02-24, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Humans; Pancreatic Neoplasms; Quinuclidines; Tumor Suppressor Protein p53

2022
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma.
    Gut, 2015, Volume: 64, Issue:10

    Topics: Adenocarcinoma; Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Mice; Mice, Knockout; Mutation; Neoplasms, Experimental; Quinuclidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2015
Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Vomiting

2012
PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis.
    Oncogene, 2005, May-12, Volume: 24, Issue:21

    Topics: Adenocarcinoma; Animals; Apoptosis; Aza Compounds; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Interactions; Drug Resistance, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Osteosarcoma; Quinuclidines; Transplantation, Heterologous; Tumor Cells, Cultured

2005
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
    JAMA, 1995, Aug-09, Volume: 274, Issue:6

    Topics: Adenocarcinoma; Aged; Cardia; Case-Control Studies; Causality; Chlordiazepoxide; Cholinergic Antagonists; Drug Combinations; Esophageal Diseases; Esophageal Neoplasms; Esophagitis; Gastroesophageal Reflux; Hernia, Hiatal; Histamine H2 Antagonists; Humans; Logistic Models; Middle Aged; Quinuclidines; Risk Factors; Stomach Neoplasms

1995